v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net income (loss) $ 54,974 $ (22,031)
Adjustments to net income (loss):    
Depreciation and amortization 329,699 317,826
Deferred income tax expense (benefit) 12,245 11,239
Impairments and other charges 31,102  
Amortization of debt discount and deferred financing costs 4,388 4,527
Bargain purchase gain (116,499)  
Losses (gains) on debt buyback (1,914) 2,576
Losses (gains) on sale of long-lived assets, net (15,831) 11,111
Share-based compensation 8,642 7,732
Foreign currency transaction losses (gains), net 2,087 17,894
Mark-to-market (gain) loss on warrants (7,399) (9,594)
Other 2,232 2,990
Changes in operating assets and liabilities, net of effects from acquisitions:    
Accounts receivable (15,981) (20,044)
Inventory 20,357 (1,574)
Other current assets (34,887) (8,023)
Other long-term assets (843) 57
Trade accounts payable and accrued liabilities (23,682) 887
Income taxes payable (6,792) (12,893)
Other long-term liabilities (2,353) (13,782)
Net cash provided by (used for) operating activities 239,545 288,898
Cash flows from investing activities:    
Purchases of investments (1,782) (7,625)
Cash acquired in stock based business combination, net of cash paid 84,429  
Capital expenditures (343,865) (231,995)
Proceeds from sales of assets 42,855 7,860
Other 7,500 4,662
Net cash (used for) provided by investing activities (210,863) (227,098)
Cash flows from financing activities:    
Reduction in debt (190,270) (631,043)
Debt issuance costs   (1,343)
Proceeds from revolving credit facilities 318,000 130,000
Reduction in revolving credit facilities (140,000) (130,000)
Payment of dividend to former Parker shareholders (6,052)  
Payments for employee taxes on net settlement of equity awards (2,151) (2,634)
Dividends to common and preferred shareholders   (87)
Distributions to noncontrolling interest (875) (950)
Other   (282)
Net cash (used for) provided by financing activities (21,348) (636,339)
Effect of exchange rate changes on cash and cash equivalents (2,203) (9,197)
Net increase (decrease) in cash and cash equivalents and restricted cash 5,131 (583,736)
Cash and cash equivalents and restricted cash, beginning of period 722,960 1,374,182
Cash and cash equivalents and restricted cash, end of period 728,091 790,446
RECONCILIATION OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH    
Cash and cash equivalents, beginning of period 389,652 1,057,487
Restricted cash, beginning of period 333,308 316,695
Cash and cash equivalents and restricted cash, beginning of period 722,960 1,374,182
Cash and cash equivalents, end of period 387,321 465,953
Restricted cash, end of period $ 340,770 $ 324,493
Restricted cash, Balance Sheet location Restricted cash held in trust Restricted cash held in trust
Cash and cash equivalents and restricted cash, end of period $ 728,091 $ 790,446